EVMN Evommune, Inc. Common Stock
$21,53
Fiyat · May 20, 2026
Temel veriler itibarıyla May 7, 2026
52 Haftlık Aralık
$14–$33
40% of range
Analist Derecelendirmesi
BUY
16 analysts
Fiyat Hedefi
$52
+142% upside
P/E (TTM)
-1.5
ROE
-401.2%
Net Kâr Marjı
-529.8%
EVMN Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$21.52
Piyasa Değeri
$540M
P/E (TTM)
-1.5
EPS (TTM)
$-11.22
Gelir (TTM)
$13M
Temettü Verimi
—
ROE
-401.2%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$14 – $33
EVMN Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$13M
2024-12-31
→
2025-12-31
Hisse Başına Kâr
$-11.22
2024-12-31
→
2025-12-31
Serbest Nakit Akışı
$-77M
2025-12-31
→
2025-12-31
Marjlar
-529.8%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
EVMN
Akran Ortalaması
P/E (TTM)
-1.5
—
P/S (TTM) (F/S (TTM))
41.5
16.8
P/B (F/D)
2.6
2.7
Price / FCF (Fiyat / Serbest Nakit Akışı)
-7.0
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
EVMN
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-623.6%
—
Net Profit Margin (Net Kâr Marjı)
-529.8%
-205.9%
ROA
-45.8%
-51.1%
ROE
-401.2%
-65.4%
ROIC
-39.4%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
EVMN
Akran Ortalaması
Current Ratio (Cari Oran)
8.6
7.7
Quick Ratio (Cari Oran)
8.3
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
EVMN
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
85.7%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
EVMN
Akran Ortalaması
EVMN Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
16 analist
- Güçlü Al 6 37,5%
- Al 9 56,2%
- Tut 1 6,2%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
8 analist · 2026-05-14
Medyan
$52.00
← Tüm hedeflerin altında
$21.52
Düşük
$48.00
Yüksek
$55.00
Medyan hedef
$52.00
+141,6%
Ortalama hedef
$52.00
+141,6%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.21%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.64 | $-0.74 | 0.10% |
| 31 Aralık 2025 | $-1.43 | $-0.90 | -0.53% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| ORIC | $806M | -5.6 | — | — | -36.5% | — |
| ANNX | $750M | -3.7 | — | — | -100.7% | — |
| CTMX | $725M | — | -44.8% | -22.8% | -15.9% | — |
| GERN | $845M | -10.2 | -60.2% | — | -34.4% | — |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Revenue | $13M | $7M | |
| R&D Expense | $74M | $64M | |
| SG&A Expense | $20M | $13M | |
| Operating Expenses | $94M | $77M | |
| Operating Income | $-81M | $-70M | |
| Interest Income | $3M | $3M | |
| Other Non-op | $12M | $3M | |
| Pretax Income | $-69M | $-68M | |
| Income Tax | $0 | $0 | |
| Net Income | $-69M | $-67M | |
| EPS (Basic) | $-11.22 | $-45.29 | |
| EPS (Diluted) | $-11.22 | $-45.29 | |
| Shares (Basic) | 6,136,636 | 1,508,284 | |
| Shares (Diluted) | 6,136,636 | 1,508,284 | |
| EBITDA | $-80M | · |
Bilanço 20
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $44M | $16M | |
| Short-term Investments | $105M | $56M | |
| Prepaid Expense | $4M | $2M | |
| Current Assets | $153M | $74M | |
| PP&E (Net) | $994.0K | $1M | |
| PP&E (Gross) | $3M | $2M | |
| Accum. Depreciation | $2M | $948.0K | |
| Other Non-current Assets | $101.0K | $61.0K | |
| Total Assets | $225M | $76M | |
| Accounts Payable | $8M | $8M | |
| Accrued Liabilities | $10M | $7M | |
| Current Liabilities | $18M | $28M | |
| Capital Leases | $1M | · | |
| Other Non-current Liabilities | · | $535.0K | |
| Total Liabilities | $19M | $29M | |
| Common Stock | $3.0K | $0 | |
| Retained Earnings | $-221M | $-152M | |
| Stockholders' Equity | $206M | $-144M | |
| Liabilities + Equity | $225M | $76M | |
| Shares Outstanding | 31,524,093 | 1,551,420 |
Nakit Akışı 9
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| D&A | $600.0K | $500.0K | |
| Stock-based Comp | $6M | $2M | |
| Other Non-cash | $-14M | · | |
| Operating Cash Flow | $-76M | $-58M | |
| CapEx | $235.0K | $88.0K | |
| Investing Cash Flow | $-115M | $-4M | |
| Financing Cash Flow | $221M | $49M | |
| Net Change in Cash | $29M | $-13M | |
| Free Cash Flow | $-77M | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -623.6% | · | |
| Net Margin | -529.8% | · | |
| Pretax Margin | -529.8% | · | |
| EBITDA Margin | -619.0% | · | |
| ROA | -45.8% | · | |
| ROE | -401.2% | · | |
| ROIC | -39.4% | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 8.6 | · | |
| Quick Ratio | 8.3 | · |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 85.7% | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $13M | · | |
| Net Income TTM | $-69M | · | |
| Market Cap | $540M | · | |
| P/E | -1.5 | · | |
| P/S | 41.5 | · | |
| P/B | 2.6 | · | |
| P / Tangible Book | 2.6 | · | |
| P / Cash Flow | -7.1 | · | |
| P / FCF | -7.0 | · | |
| Earnings Yield | -65.5% | · |
Gelir Tablosu 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $10M | $3M | $0 | |
| R&D Expense | $17M | $20M | $20M | $14M | $18M | |
| SG&A Expense | $7M | $9M | $4M | $4M | $4M | |
| Operating Expenses | $24M | $30M | $23M | $18M | $21M | |
| Operating Income | $-24M | $-30M | $-13M | $-15M | $-21M | |
| Interest Income | $2M | $1M | $862.0K | $613.0K | $727.0K | |
| Other Non-op | $2M | $1M | $853.0K | $475.0K | $728.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-22M | $-28M | $-12M | $-15M | $-21M | |
| EPS (Basic) | $-0.64 | $15.14 | $-8.07 | $-9.48 | $-14.60 | |
| EPS (Diluted) | $-0.64 | $15.14 | $-8.07 | $-9.48 | $-14.60 | |
| Shares (Basic) | 33,670,148 | 4,596,393 | 1,545,010 | 1,534,965 | 6,649 | |
| Shares (Diluted) | 33,670,148 | 4,596,393 | 1,545,010 | 1,534,965 | 6,649 | |
| EBITDA | $-24M | · | $-13M | · | · |
Bilanço 20
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $44M | $27M | · | $16M | |
| Short-term Investments | $163M | $105M | $49M | · | $56M | |
| Prepaid Expense | $4M | $4M | $6M | · | $2M | |
| Current Assets | $216M | $153M | $82M | · | $74M | |
| PP&E (Net) | $2M | $994.0K | $970.0K | · | $1M | |
| PP&E (Gross) | $3M | $3M | · | · | $2M | |
| Accum. Depreciation | $1M | $2M | · | · | $948.0K | |
| Other Non-current Assets | $73.0K | $101.0K | $61.0K | · | $61.0K | |
| Total Assets | $322M | $225M | $85M | · | $76M | |
| Accounts Payable | $4M | $8M | $4M | · | $8M | |
| Accrued Liabilities | $5M | $10M | $6M | · | $7M | |
| Current Liabilities | $11M | $18M | $10M | · | $28M | |
| Capital Leases | $7M | $1M | $0 | · | · | |
| Other Non-current Liabilities | · | · | $261.0K | · | · | |
| Total Liabilities | $18M | $19M | $11M | · | $29M | |
| Common Stock | $4.0K | $3.0K | $0 | · | $0 | |
| Retained Earnings | $-243M | $-221M | $-193M | · | $-152M | |
| Stockholders' Equity | $305M | $206M | $-183M | · | $-144M | |
| Liabilities + Equity | $322M | $225M | $85M | · | $76M | |
| Shares Outstanding | 36,018,372 | 31,524,093 | 1,554,965 | · | 1,551,420 |
Nakit Akışı 9
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| D&A | $100.0K | $326.0K | · | $200.0K | $360.0K | |
| Stock-based Comp | $3M | $4M | · | $544.0K | $494.0K | |
| Other Non-cash | $-9M | · | · | · | · | |
| Operating Cash Flow | $-28M | $-17M | · | $-24M | $-19M | |
| CapEx | $83.0K | $104.0K | · | $0 | $0 | |
| Investing Cash Flow | $-85M | $-123M | · | $14M | $-33M | |
| Financing Cash Flow | $117M | $157M | · | $-152.0K | $50M | |
| Net Change in Cash | $4M | $17M | · | $-11M | $-2M | |
| Free Cash Flow | $-28M | · | · | · | · |
Kârlılık 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Operating Margin | · | · | -133.3% | · | · | |
| Net Margin | · | · | -124.8% | · | · | |
| EBITDA Margin | · | · | -133.3% | · | · | |
| ROA | -13.4% | · | -29.5% | · | · | |
| ROE | -14.2% | · | 13.6% | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Current Ratio | 20.4 | · | 7.9 | · | · | |
| Quick Ratio | 19.9 | · | 7.3 | · | · |
Verimlilik 1
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.2 | · | · |
Değerleme (TTM) 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Market Cap | $828M | · | · | · | · | |
| P/B | 2.7 | · | · | · | · | |
| P / Tangible Book | 2.7 | · | · | · | · | |
| P / Cash Flow | -30.1 | · | · | · | · | |
| P / FCF | -30.0 | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Gelir | $13M | $7M |
| Faaliyet Kâr Marjı % | -623.6% | — |
| Net Gelir | $-69M | $-67M |
| Seyreltilmiş Hisse Başı Kâr | $-11.22 | $-45.29 |
Bilanço
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Cari Oran | 8.6 | — |
| Cari Oran | 8.3 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Serbest Nakit Akışı | $-77M | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.